Back to Results
First PageMeta Content
Chemistry / Bristol-Myers Squibb / Organic chemistry / Business / Clopidogrel / Prodrugs / Sanofi / RTT / Antiplatelet drug / Thienopyridine / Stroke / Prasugrel


Ann Arbor, MIDiapin Therapeutics, LLC., a company dedicated to the development of treatments for type 2 diabetes and cardiovascular disease, announced today the signing of a license agreement with the Univer
Add to Reading List

Document Date: 2015-03-10 10:24:06


Open Document

File Size: 66,45 KB

Share Result on Facebook